易布鲁替尼直接减少CD8+T细胞耗尽,独立于BTK
Ling Li1, Manzhi Zhao1, Caoimhe H Kiernan1
1Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands.
Frontiers in immunology
|September 29, 2023
概括
易布鲁替尼直接通过减少抑制受体和增强细胞因子生产来逆转细胞毒性CD8+T细胞 (CTL) 疲劳. 这一发现支持ibrutinib的发现.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞毒性CD8+T细胞 (CTL) 耗尽会损害抗瘤免疫力.
- 免疫检查点阻塞疗法在逆转T细胞枯竭方面表现有前途.
- 一种BTK抑制剂易布鲁替尼,已显示T细胞增强作用,但机制尚不清楚.
研究的目的:
- 调查一下易布鲁替尼能否直接使已耗尽的CTLs恢复活力.
- 阐明易布鲁替尼对T细胞枯竭的影响机制.
主要方法:
- 利用一个体外CTL耗尽系统来测试ibrutinib的直接作用.
- 通过流式细胞计量评估抑制受体,细胞因子生产和转录因子 (TOX,TCF1) 的变化.
- 进行RNA测序来分析转录特征,并使用BTK缺乏的小鼠来确认BTK独立性.
主要成果:
- 易布鲁替尼减少了疲劳标志物,包括抑制性受体,并在耗尽的CTL中增强了细胞因子的产生.
- 观察到TOX的下调和TCF1的上调.
- RNA-seq证实了与疲劳相关的转录特征的直接逆转.
- 易布鲁替尼的效应与BTK表达独立.
结论:
- 易布鲁替尼直接改善了CTL疲.
- 这些发现表明,ibrutinib与癌症免疫治疗的潜在协同使用.
相关概念视频
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
01:27Cytotoxic T Cells-mediated Immune Response
956
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
956